FindTrial
Sign In

A Study on Establishing the Local Reference Interval of Serum Markers Ceruloplasmin in Healthy Populations Based on Laboratory Data

A Study on Establishing the Local Reference Interval of Serum Markers Ceruloplasmin in Healthy Populations Based on Laboratory Data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118992
Enrollment
Unknown
Registered
2026-02-13
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Populations

Interventions

Trial group:NA

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Individuals aged >= 18 years. Clinical diagnosis or health examination indicates no known diseases affecting ceruloplasmin levels, such as liver diseases, nervous system lesions, rheumatoid immune diseases, and malignant tumors. Meanwhile, the simultaneously detected liver function indicators (e.g., ALT, AST) and blood routine parameters are within the normal reference range of our hospital.

Exclusion criteria

Exclusion criteria: 1.Records with incomplete data or inconsistent detection methods. Patients with a recent blood transfusion history or those using drugs that may affect ceruloplasmin levels.

Design outcomes

Primary

MeasureTime frame
Serum ceruloplasmin concentration;—

Countries

China

Contacts

Public ContactGuangzhen Fu

The First Affiliated Hospital of Zhengzhou University

fuguangzhen1987@163.com+86 371 67966125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026